Becker's Healthcare October 4, 2022
Alexion Pharmaceuticals, a subsidiary of the drugmaker AstraZeneca, plans to acquire LogicBio Therapeutics, a gene therapy company.
AstraZeneca’s offer price is $2.07 per share, the company said in an Oct. 3 news release, making the...